Kliiniset tiedot

3rd August 2026

Sustained symptom relief and safety over five years following a single intra-articular injection of 2.5% polyacrylamide hydrogel in patients with knee osteoarthritis

13th February 2026

A prospective, open-label, clinical investigation of a single intra-articular polyacrylamide hydrogel injection in participants with knee osteoarthritis: a 5-year extension study

28th November 2025

Three-year follow-up from a randomised controlled trial of a single intra-articular polyacrylamide hydrogel injection in subjects with knee osteoarthritis

14th October 2025

10-year follow-up after intra-articular injections of 2.5 % polyacrylamide hydrogel for knee osteoarthritis

21st November 2024

Polyacrylamide hydrogel for knee osteoarthritis: four-year results from a prospective study

1st October 2024

P081 Polyacrylamide Hydrogel for Knee OA 4 year Results from A Prospective Study ICRS 2024 Summit e-poster

23rd September 2024

Polyacrylamide gel versus hyaluronic acid for the treatment of knee osteoarthritis: a randomised controlled study

12th September 2024

POLYACRYLAMIDE HYDROGEL VERSUS HYALURONIC ACID IN KNEE OSTEOARTHRITIS: A SUBGROUP ANALYSIS OF A RANDOMIZED STUDY

25th June 2024

LB-098 Inflammatory markers in the knee in patients with osteoarthritis assessed with ultrasound: a secondary analysis of a randomized controlled trial of Arthrosamid vs. Synvisc-One

24th June 2024

LB-031 3 YEAR FOLLOW-UP FROM A RANDOMISED CONTROLLED TRIAL OF INTRA-ARTICULAR POLYACRYLAMIDE HYDROGEL INJECTION IN SUBJECTS WITH KNEE OSTEOARTHRITIS

21st June 2024

Painful knee independant risk factor for mortality

2nd May 2024

Effectiveness and safety of polyacrylamide hydrogel injection for knee osteoarthritis: results from a 12‑month follow up of an open‑label study

30th June 2023

POS1130 A RANDOMISED CONTROLLED STUDY OF POLYACRYLAMIDE HYDROGEL VS. HYALURONIC ACID IN KNEE OSTEOARTHRITIS: RESULTS AT 12-MONTHS

30th June 2023

AB1185 POLYACRYLAMIDE HYDROGEL FOR THE TREATMENT OF KNEE OSTEOARTHRITIS: 3 YEAR FOLLOW UP RESULTS OF A PROSPECTIVE CLINICAL STUDY

31st May 2023

IDA 3 Years - Poster 483 presented at OARSI 2023

25th August 2022

ROSA 12 Months Study - Poster 491 OARSI 2022

25th August 2022

IDA Two Year Study - Poster 493 OARSI 2022

25th August 2022

ROSA SUBGROUP Study - Poster 496 OARSI 2022

9th August 2022

Synovitis in osteoarthritis: current understanding with therapeutic implications

9th August 2022

The importance of synovial inflammation in osteoarthritis: current evidence from imaging assessments and clinical trials

10th May 2022

One-Year Performance of Polyacrylamide Hydrogel Vs. Hyaluronic Acid: A Randomised Controlled Study. OARSI World Congress on Osteoarthritis, Berlin. 7-10 April 2022

10th May 2022

A Prospective Study of Polyacrylamide Hydrogel for Knee Osteoarthritis: Results from 2 Years after Treatment.” OARSI World Congress on Osteoarthritis, Berlin. 7-10 April 2022

10th May 2022

One-Year Performance of Polyacrylamide Hydrogel Vs. Hyaluronic Acid in Age, BMI and Kellgren-Lawrence Subgroups: A Subgroup Analysis of a Randomised Study. OARSI World Congress on Osteoarthritis, Berlin. 7-10 April 2022

9th May 2022

Polyacrylamide Hydrogel Injection for Knee Osteoarthritis: A 6 Months Prospective Study

9th May 2022

Treatment of Knee Osteoarthritis With PAAG-OA (ROSA)

9th May 2022

PAAG-OA Treatment for Knee Osteoarthritis (IDA)

18th November 2021

IDA 12 Months Study - OARSI Connect 2021 Poster 336

28th July 2021

Non-surgical treatment of knee osteoarthritis

1st June 2021

2.5% polyacrylamide hydrogel - an observational proof-of-concept cohort study.

3rd May 2021

Polyacrylamide hydrogel injection for knee osteoarthritis: results of a 52 week prospective study

1st May 2021

Quality of life after total knee arthroplasty

1st April 2021

Epidemiology of Osteoarthritis

1st January 2021

Osteoarthritis: the genesis of pain